Top

Published in:

01-05-2015 | Original Article

General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care

Authors: Karin Bergkvist, Jeanette Winterling, Eva Johansson, Unn-Britt Johansson, Britt-Marie Svahn, Mats Remberger, Jonas Mattsson, Joacim Larsen

Published in: Supportive Care in Cancer | Issue 5/2015

Abstract

Purpose

Earlier studies have shown that home care during the neutropenic phase after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is medically safe, with positive outcomes. However, there have been few results on long-term outcomes after home care. The aims of this study were to compare general health, symptom occurrence, and self-efficacy in adult survivors who received either home care or hospital care during the early neutropenic phase after allo-HSCT and to investigate whether demographic or medical variables were associated with general health or symptom occurrence in this patient population.

Methods

In a cross-sectional survey, 117 patients (hospital care: n = 78; home care: n = 39) rated their general health (SF-36), symptom occurrence (SFID-SCT, HADS), and self-efficacy (GSE) at a median of 5 (1–11) years post-HSCT.

Results

No differences were found regarding general health, symptom occurrence, or self-efficacy between groups. The majority of patients in both hospital care (77 %) and home care (78 %) rated their general health as “good” with a median of 14 (0–36) current symptoms. Symptoms of fatigue and sexual problems were among the most common. Poor general health was associated with acute graft-versus-host disease (GVHD), low self-efficacy, and cord blood stem cells. A high symptom occurrence was associated with female gender, acute GVHD, and low self-efficacy.

Conclusions

No long-term differences in general health and symptom occurrence were observed between home care and hospital care. Thus, home care is an alternative treatment method for patients who for various reasons prefer this treatment option. We therefore encourage other centers to offer home care to patients.

Gyurkocza B, Rezvani A, Storb RF (2010) Allogeneic hematopoietic cell transplantation: the state of the art. Expert Rev Hematol 3(3):285–299. doi:10.1586/ehm.10.21 CrossRefPubMedCentralPubMed

Remberger M, Ackefors M, Berglund S, Blennow O, Dahllof G, Dlugosz A, Garming-Legert K, Gertow J, Gustafsson B, Hassan M, Hassan Z, Hauzenberger D, Hagglund H, Karlsson H, Klingspor L, Kumlien G, Le Blanc K, Ljungman P, Machaczka M, Malmberg KJ, Marschall HU, Mattsson J, Olsson R, Omazic B, Sairafi D, Schaffer M, Svahn BM, Svenberg P, Swartling L, Szakos A, Uhlin M, Uzunel M, Watz E, Wernerson A, Wikman A, Wikstrom AC, Winiarski J, Ringden O (2011) Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 17(11):1688–1697. doi:10.1016/j.bbmt.2011.05.001 CrossRef

Russell JA, Poon MC, Jones AR, Woodman RC, Ruether BA (1992) Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 339(8784):38–40CrossRefPubMed

Svahn BM, Bjurman B, Myrback KE, Aschan J, Ringden O (2000) Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial. Bone Marrow Transplant 26(10):1057–1060CrossRefPubMed

Solomon SR, Matthews RH, Barreras AM, Bashey A, Manion KL, McNatt K, Speckhart D, Connaghan DG, Morris LE Jr, Holland HK (2010) Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM. Bone Marrow Transplant 45(3):468–475. doi:10.1038/bmt.2009.234 CrossRefPubMed

McDiarmid S, Hutton B, Atkins H, Bence-Bruckler I, Bredeson C, Sabri E, Huebsch L (2010) Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes. Bone Marrow Transplant 45(7):1220–1226. doi:10.1038/bmt.2009.330 CrossRefPubMed

Svahn BM, Ringden O, Remberger M (2005) Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 36(6):511–516. doi:10.1038/sj.bmt.1705096 CrossRefPubMed

Ringden O, Remberger M, Holmberg K, Edeskog C, Wikstrom M, Eriksson B, Finnbogadottir S, Fransson K, Milovsavljevic R, Omazic B, Svenberg P, Mattsson J, Svahn BM (2013) Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 19(2):314–320. doi:10.1016/j.bbmt.2012.10.011 CrossRef

Garnett C, Apperley JF, Pavlu J (2013) Treatment and management of graft-versus-host disease: improving response and survival. Therapeutic Adv Hematol 4(6):366–378. doi:10.1177/2040620713489842 CrossRef

10.

Braamse AM, Gerrits MM, van Meijel B, Visser O, van Oppen P, Boenink AD, Cuijpers P, Huijgens PC, Beekman AT, Dekker J (2012) Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant 47(6):757–769. doi:10.1038/bmt.2011.130 CrossRefPubMed

11.

Pidala J, Anasetti C, Jim H (2009) Quality of life after allogeneic hematopoietic cell transplantation. Blood 114(1):7–19. doi:10.1182/blood-2008-10-182592 CrossRefPubMedCentralPubMed

12.

Lee SJ, Kim HT, Ho VT, Cutler C, Alyea EP, Soiffer RJ, Antin JH (2006) Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 38(4):305–310. doi:10.1038/sj.bmt.1705434 CrossRefPubMed

13.

Ringden O, Hermans J, Labopin M, Apperley J, Gorin NC, Gratwohl A (1996) The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT). Leuk Lymphoma 24(1–2):71–79. doi:10.3109/10428199609045715 CrossRefPubMed

14.

Majhail NS, Rizzo JD (2013) Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant 48(9):1145–1151. doi:10.1038/bmt.2012.258 CrossRefPubMed

15.

Syrjala KL, Martin PJ, Lee SJ (2012) Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol 30(30):3746–3751. doi:10.1200/JCO.2012.42.3038 CrossRef

16.

Pallua S, Giesinger J, Oberguggenberger A, Kemmler G, Nachbaur D, Clausen J, Kopp M, Sperner-Unterweger B, Holzner B (2010) Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 45(10):1534–1539. doi:10.1038/bmt.2010.5 CrossRefPubMed

17.

Hows JM, Passweg JR, Tichelli A, Locasciulli A, Szydlo R, Bacigalupo A, Jacobson N, Ljungman P, Cornish J, Nunn A, Bradley B, Socie G, Centers ISP, Late Effects Working Party of the European Group for B, Marrow T (2006) Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant 38(12):799–805. doi:10.1038/sj.bmt.1705531 CrossRefPubMed

18.

Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ (2005) Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol Off J Am Soc Clin Oncol 23(27):6596–6606. doi:10.1200/JCO.2005.12.674 CrossRef

19.

Lee SJ, Fairclough D, Parsons SK, Soiffer RJ, Fisher DC, Schlossman RL, Antin JH, Weeks JC (2001) Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol Off J Am Soc Clin Oncol 19(1):242–252

20.

Bandura A (2001) Social cognitive theory: an agentic perspective. Annu Rev Psychol 52:1–26. doi:10.1146/annurev.psych.52.1.1 CrossRefPubMed

21.

Bandura A (1997) Self-efficacy: the exercise of control. W.H Freeman and Company, Ney York

22.

Mystakidou K, Tsilika E, Parpa E, Gogou P, Theodorakis P, Vlahos L (2010) Self-efficacy beliefs and levels of anxiety in advanced cancer patients. Eur J Cancer Care 19(2):205–211. doi:10.1111/j.1365-2354.2008.01039.x CrossRef

23.

Kohno Y, Maruyama M, Matsuoka Y, Matsushita T, Koeda M, Matsushima E (2010) Relationship of psychological characteristics and self-efficacy in gastrointestinal cancer survivors. Psycho-Oncology 19(1):71–76. doi:10.1002/pon.1531 CrossRefPubMed

24.

Bergkvist K, Larsen J, Johansson UB, Mattsson J, Svahn BM (2013) Hospital care or home care after allogeneic hematopoietic stem cell transplantation—patients’ experiences of care and support. Eur J Oncol Nurs 17(4):389–395. doi:10.1016/j.ejon.2012.12.004 CrossRefPubMed

25.

Winterling J, Johansson E, Wennman-Larsen A, Petersson LM, Ljungman P, Alexanderson K (2014) Occupational status among adult survivors following allo-SCT. Bone Marrow Transplant. doi:10.1038/bmt.2014.26 PubMed

26.

Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P, Aschan J, Barkholt L, Ringden O (2002) Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 100(13):4317–4324CrossRefPubMed

27.

Olsson R, Remberger M, Hassan Z, Omazic B, Mattsson J, Ringden O (2010) GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants. Eur J Haematol 84(4):323–331. doi:10.1111/j.1600-0609.2009.01390.x CrossRefPubMed

28.

Forslow U, Blennow O, LeBlanc K, Ringden O, Gustafsson B, Mattsson J, Remberger M (2012) Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation. Eur J Haematol 89(3):220–227. doi:10.1111/j.1600-0609.2012.01824.x CrossRefPubMed

29.

Petersson LM, Wennman-Larsen A, Nilsson M, Olsson M, Alexanderson K (2011) Work situation and sickness absence in the initial period after breast cancer surgery. Acta Oncol (Stockholm, Sweden) 50(2):282–288. doi:10.3109/0284186X.2010.533191 CrossRef

30.

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30(6):473–483CrossRefPubMed

31.

Larsen J, Nordstrom G, Ljungman P, Gardulf A (2004) Symptom occurrence, symptom intensity, and symptom distress in patients undergoing high-dose chemotherapy with stem-cell transplantation. Cancer Nurs 27(1):55–64CrossRefPubMed

32.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed

33.

Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77CrossRefPubMed

34.

Bland JM, Altman DG (1997) Cronbach’s alpha. BMJ 314(7080):572CrossRefPubMedCentralPubMed

35.

Schwarzer R, Jerusalem M (1995) Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M (eds) Measures in health psychology: a user’s portfolio. Causal and control beliefs. NFER-NELSON, Windsor, pp 35–37

36.

Labriola M, Lund T, Christensen KB, Albertsen K, Bultmann U, Jensen JN, Villadsen E (2007) Does self-efficacy predict return-to-work after sickness absence? A prospective study among 930 employees with sickness absence for 3 weeks or more. Work 29(3):233–238PubMed

37.

Iacobelli S (2013) Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 48(Suppl 1):S1–S37. doi:10.1038/bmt.2012.282 CrossRefPubMed

38.

Svahn BM, Remberger M, Heijbel M, Martell E, Wikstrom M, Eriksson B, Milovsavljevic R, Mattsson J, Ringden O (2008) Case–control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation 85(7):1000–1007CrossRefPubMed

39.

Bostrom L, Ringden O, Gratama JW, Jacobsen N, Prentice HG, Zwaan FE, Nilsson B (1990) A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 5(5):321–326PubMed

40.

Reddy P, Ferrara JL (2003) Immunobiology of acute graft-versus-host disease. Blood Rev 17(4):187–194CrossRefPubMed

41.

Fondell E, Axelsson J, Franck K, Ploner A, Lekander M, Balter K, Gaines H (2011) Short natural sleep is associated with higher T cell and lower NK cell activities. Brain Behav Immun 25(7):1367–1375. doi:10.1016/j.bbi.2011.04.004 CrossRefPubMed

42.

Mattsson J, Westin S, Edlund S, Remberger M (2006) Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease. Bone Marrow Transplant 38(9):629–633CrossRefPubMed

43.

Berglund S, Le Blanc K, Remberger M, Gertow J, Uzunel M, Svenberg P, Winiarski J, Ljungman P, Ringden O, Uhlin M, Mattsson J (2012) Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation. Transplantation 94(10):1066–1074. doi:10.1097/TP.0b013e31826c39b2 CrossRefPubMed

44.

Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psycho-Oncology. doi:10.1002/pon.3128 PubMed

45.

Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S, Henslee-Downey J (2007) Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. J Psychosoc Oncol 25(1):87–101. doi:10.1300/J077v25n01_05 CrossRefPubMed

46.

Hirai K, Suzuki Y, Tsuneto S, Ikenaga M, Hosaka T, Kashiwagi T (2002) A structural model of the relationships among self-efficacy, psychological adjustment, and physical condition in Japanese advanced cancer patients. Psycho-Oncology 11(3):221–229. doi:10.1002/pon.561 CrossRefPubMed

47.

Khera N, Chow EJ, Leisenring WM, Syrjala KL, Baker KS, Flowers ME, Martin PJ, Lee SJ (2011) Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 17(7):995–1003. doi:10.1016/j.bbmt.2010.10.023 CrossRef

48.

Wong FL, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C, Sabado M, Grant M, Forman SJ, Bhatia S (2010) Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 115(12):2508–2519. doi:10.1182/blood-2009-06-225631 CrossRefPubMedCentralPubMed

49.

Edman L, Larsen J, Hagglund H, Gardulf A (2001) Health-related quality of life, symptom distress and sense of coherence in adult survivors of allogeneic stem-cell transplantation. Eur J Cancer Care 10(2):124–130CrossRef

50.

Tierney DK, Facione N, Padilla G, Dodd M (2007) Response shift: a theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs 30(2):125–138. doi:10.1097/01.NCC.0000265002.79687.af CrossRefPubMed

51.

Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515CrossRefPubMed

52.

Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G (2007) Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 39(10):595–603. doi:10.1038/sj.bmt.1705624 CrossRefPubMed

53.

Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H, Kaasa S (2004) A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 34(3):257–266. doi:10.1038/sj.bmt.1704561 CrossRefPubMed

54.

Thygesen KH, Schjodt I, Jarden M (2012) The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 47(5):716–724. doi:10.1038/bmt.2011.169 CrossRefPubMed

55.

Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH (2011) Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer 19(9):1357–1365. doi:10.1007/s00520-010-0958-y CrossRefPubMedCentralPubMed

56.

Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E, Espinal A, Gasto C (2005) Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol 23(25):6063–6071. doi:10.1200/JCO.2005.05.751 CrossRef

57.

Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR (2005) Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol 23(3):599–608. doi:10.1200/JCO.2005.03.189 CrossRef

Title: General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care
Authors: Karin Bergkvist
Jeanette Winterling
Eva Johansson
Unn-Britt Johansson
Britt-Marie Svahn
Mats Remberger
Jonas Mattsson
Joacim Larsen
Publication date: 01-05-2015
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 5/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2476-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2015

Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia

Evaluation of histopathological findings at the injection site following degarelix administration

An analysis of the distress thermometer problem list and distress in patients with cancer

Measurement of chemotherapy-induced alopecia—time to change

Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study

Use of cancer-specific mental health resources—is there an urban-rural divide?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer